Liangli Zhao

Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling

Liangli Zhao, Brian Y. Lee, David A. Brown et al. · Cancer Research · 2009 · 101 citations

Docetaxel Chemotherapy, Pathology, Therapeutic Response +24

Mechanisms of tumor vascular shutdown induced by 5,6‐dimethylxanthenone‐4‐acetic acid (DMXAA): Increased tumor vascular permeability

Liangli Zhao, Lai‐Ming Ching, Philip Kestell et al. · International Journal of Cancer · 2005 · 71 citations

Measurement of plasma 5-hydroxyindoleacetic acid as a possible clinical surrogate marker for the action of antivascular agents

Philip Kestell, Liangli Zhao, Michael B. Jameson et al. · Clinica Chimica Acta · 2001 · 32 citations

Thrombosis, Hypertension, Vascular Disease +11

Studies on the mechanism of cancer protection by wheat bran: effects on the absorption, metabolism and excretion of the food carcinogen 2-amino-3-methylimidazo[4,5- f ]quinoline (IQ)

Philip Kestell, Liangli Zhao, Shuotun Zhu et al. · Carcinogenesis · 1999 · 29 citations · Full text

Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomide

Philip Kestell, Liangli Zhao, Bruce C. Baguley et al. · Cancer Chemotherapy and Pharmacology · 2000 · 25 citations

Medicinal Chemistry, Pharmacological Study, Pharmacology +5